Chronic Disease Management Market Research, Size, Revenue Growth Trends, Analysis Till 2030

 

The chronic disease management market was valued USD 4.69 billion in 2021 and is expected to reach USD 15.82 Billion by 2030 at 13.82% CAGR during the forecast period 2022-2030.

There are wide market for chronic diseases management globally owing to its application in various field such as asthma, cancer, cardiovascular, diabetes, stroke and many more. Increasing prevalence of chronic disease globally considering the major factor which lead the growth of chronic diseases management market globally. According to a Cancer research U.K, in 2014, around 356,860 people were diagnosed with cancer. Report suggest that it incident of cancer are rising rapidly in last few years and expected to grow quickly in the coming future owing to unhealthy diets, high rate of smoke and alcohol consumption.

One of the primary factors anticipated to fuel the rise and demand for chronic disease treatment is the global increase in the prevalence of chronic diseases such as COPD, asthma, cancer, diabetes, stroke, or musculoskeletal problems. Increasing prevalence of chronic disease, rising demand for better treatment, increasing investment in Research and development, and availability of funds drive the growth of the market. Moreover, increasing government support, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period.

Regional Analysis

The Americas dominate the global chronic diseases management market research owing to the presence of huge patient population with chronic diseases, and increasing government support for research & development. Furthermore market players of this region continues involve in providing quality product which give an edge to this region in leading globally.

Europe holds the second largest share of the global chronic diseases management market as result of increasing focus of various government agencies on the treatment of chronic diseases. Moreover, the growing public awareness about chronic diseases management likely to boost the Europe market.

Asia Pacific is the fastest growing chronic diseases management market across the globe. Japan holds a major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecast period.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global chronic diseases management market is segmented on the basis of service types, by application, by deployment, and by end user. On the basis of the service type, it is segmented into consulting service, implementation service, educational services, and others. On the basis of the application, it is segmented into asthma, cancer, cardiovascular, diabetes, stroke, and others. On the basis of the deployment, it is segmented into on premise, web based, and cloud based. On the basis of end user, it is segmented into provider and payer.

Key Players

Some of key the players in the market are TriZetto Corporation (U.S.), Phytel Inc (U.S.), Pegasystems Inc. (U.S.), AxisPoint Health (U.S.), Wellcentive, Inc, Medecision, Inc (U.S.), i2i Systems, Inc (U.S.), HealthSmart Holdings, Inc (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), ZeOmega Inc. (U.S.), Epic Corporation Inc (U.S.), Harmony Information Systems, Inc. (U.S.), Infosys Limited (India)

Get Report Details @ https://www.marketresearchfuture.com/reports/chronic-diseases-management-market-981

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Digital Pathology Market Research, Size, Revenue, Trends, Competitive Landscape Study & Analysis, Forecast To 2028

Image
  The growing number of innovations in the areas of pathology would further increase the size of the market to a great deal, in the next six years. According to MRFR, the Digital Pathology Market is expected to register a CAGR of 6.5% over the review period from 2021 to 2028 and expected to reach USD 1.4 Billion by 2028. Digital Pathology or Computational Pathology leverages completely new perceptions through data analysis, enabling pathologists to consult on treatment options. The rapidly evolving pathology sector is a key element of modern diagnostic practices. There have been several innovations and widespread adoption of digital pathology. It has long been realized that the traditional histopathology is inefficient as it exposes samples to various handlers, increasing the scope for human error. The digital pathology, on the other hand, eliminates the risk factors, while also providing the pathologist with the necessary images and clinical information to generate the most a...
Read more

Structural Heart Devices Market Size, Key Player Revenue, SWOT, PEST & Porter’s Analysis Till 2027

Image
Structural heart diseases   are problems associated with the valves or tissues of the heart. These diseases may be congenital or might be acquired later in life. Structural heart diseases include cardiomyopathy, myocarditis, aortic valve stenosis, heart valve disease, atrial septal defect, mitral valve regurgitation, and others. As per the latest report of Market Research Future (MRFR), the structural heart devices market is poised to expand at CAGR of 10.4% over the forecast period. The  structural heart devices market  is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes. In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed. A number of clinical trials and technology developments are underway, which is likely to pro...
Read more

Anal Fissure Treatment Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2030

Image
  The global  anal fissure treatment market  is expected to rise and touch a valuation of USD 2,526.5 million by 2023, at a 7.6% CAGR during the forecast period. Anal fissures are small tears near the mucosal lining of the anus. Deeper cuts may take a combination of oral and topical medicine to alleviate the pain. The anal fissure treatment market is expected to thrive owing to the booming pediatric and geriatric patient pool. Advances in technology coupled with various treatment options is likely to lead to a windfall for the market over the forecast period. High incidence of constipation is predicted to drive the need for anal fissure treatments. This is backed by vulnerability of the elderly which find it difficult to pass stools properly. According to the American Gastroenterological, nearly 33% of Americans above 60 experience the condition. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3841 Unhealthy lifestyles adopted by pat...
Read more